A Study of KW-3357 in Congenital Antithrombin Deficiency

NCT00938288 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Antithrombin Deficiency

Interventions

DRUG: KW-3357

Sponsor

Kyowa Kirin Co., Ltd.

Collaborators

[object Object]